increased glutathione in acute myeloid leukemia determines chronic vulnerability to an inhibitor of CMPK and TMPK Understanding and Targeting Metabolic Vulnerabilities
Understanding and Targeting Metabolic Vulnerabilities in Acute Myeloid Leukemia: An Updated Comprehensive Review PMC Roles of Glutathione and AP 1 in the Enhancement of Vitamin D Induced Differentiation by Activators of the Nrf2 Signaling Pathway in Acute Myeloid Leukemia Cells Metabolic reprogramming and immune regulation in acute myeloid leukemia Frontiers Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis: Trends in Cell Biology Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia ScienceDirect
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




